172 related articles for article (PubMed ID: 32614521)
1. Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.
Cheng XS; Huo YN; Fan YY; Xiao CX; Ouyang XM; Liang LY; Lin Y; Wu JF; Ren JL; Guleng B
J Cell Mol Med; 2020 Aug; 24(15):8391-8404. PubMed ID: 32614521
[TBL] [Abstract][Full Text] [Related]
2. The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
Wang LF; Liu YS; Yang B; Li P; Cheng XS; Xiao CX; Liu JJ; Li S; Ren JL; Guleng B
Oncogene; 2018 Feb; 37(5):601-615. PubMed ID: 28991232
[TBL] [Abstract][Full Text] [Related]
3. Mindin is upregulated during colitis and may activate NF-kappaB in a TLR-9 mediated manner.
Guleng B; Lian YM; Ren JL
World J Gastroenterol; 2010 Mar; 16(9):1070-5. PubMed ID: 20205276
[TBL] [Abstract][Full Text] [Related]
4. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
[TBL] [Abstract][Full Text] [Related]
5. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
[No Abstract] [Full Text] [Related]
6. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
7. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
8. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
9. Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.
Xiao M; Tang Y; Chen WW; Wang YL; Yang L; Li X; Song GL; Kuang J
Tumour Biol; 2016 Feb; 37(2):2353-63. PubMed ID: 26373733
[TBL] [Abstract][Full Text] [Related]
10. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.
Shi C; Yang Y; Xia Y; Okugawa Y; Yang J; Liang Y; Chen H; Zhang P; Wang F; Han H; Wu W; Gao R; Gasche C; Qin H; Ma Y; Goel A
Gut; 2016 Sep; 65(9):1470-81. PubMed ID: 25994220
[TBL] [Abstract][Full Text] [Related]
11. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
12. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
13. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
Fichera A; Little N; Dougherty U; Mustafi R; Cerda S; Li YC; Delgado J; Arora A; Campbell LK; Joseph L; Hart J; Noffsinger A; Bissonnette M
J Surg Res; 2007 Oct; 142(2):239-45. PubMed ID: 17574271
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
15. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro.
Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H
FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574
[TBL] [Abstract][Full Text] [Related]
16. An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research.
Wang F; Johnson RL; Snyder PW; DeSmet ML; Fleet JC
Dig Dis Sci; 2016 Apr; 61(4):1069-79. PubMed ID: 26631394
[TBL] [Abstract][Full Text] [Related]
17. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
[TBL] [Abstract][Full Text] [Related]
19. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Bai YP; Shang K; Chen H; Ding F; Wang Z; Liang C; Xu Y; Sun MH; Li YY
Cancer Sci; 2015 Oct; 106(10):1278-87. PubMed ID: 26183471
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
Yoshii S; Hayashi Y; Iijima H; Inoue T; Kimura K; Sakatani A; Nagai K; Fujinaga T; Hiyama S; Kodama T; Shinzaki S; Tsujii Y; Watabe K; Takehara T
Cancer Sci; 2019 Aug; 110(8):2396-2407. PubMed ID: 31148360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
